VolitionRx Limited Weighted Average Number of Shares Outstanding, Basic and Diluted
VolitionRx Limited (VNRX) reported Weighted Average Number of Shares Outstanding, Basic and Diluted of 52.66 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-30.
Discontinued › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted · last filed 2022-03-30
- VolitionRx Limited weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-12-31 was 53.56M shares, a 10.04% increase year-over-year.
- VolitionRx Limited weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-09-30 was 53.17M shares, a 13.06% increase year-over-year.
- VolitionRx Limited weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-06-30 was 52.95M shares, a 21.96% increase year-over-year.
- VolitionRx Limited weighted average number of shares outstanding, basic and diluted for the quarter ending 2021-03-31 was 50.93M shares, a 23.62% increase year-over-year.
- VolitionRx Limited weighted average number of shares outstanding, basic and diluted for fiscal 2021 was 52.66M shares, a 16.29% increase from fiscal 2020.
- VolitionRx Limited weighted average number of shares outstanding, basic and diluted for fiscal 2020 was 45.28M shares, a 15.57% increase from fiscal 2019.
- VolitionRx Limited weighted average number of shares outstanding, basic and diluted for fiscal 2019 was 39.18M shares, a 24.82% increase from fiscal 2018.
- VolitionRx Limited weighted average number of shares outstanding, basic and diluted for fiscal 2018 was 31.39M shares, a 18.95% increase from fiscal 2017.
| Period end | Weighted Average Number of Shares Outstanding, Basic and Diluted 3 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 6 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 9 month | Weighted Average Number of Shares Outstanding, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | 53.56M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 53.36M shares derived: average of 2 quarters · filed 2022-03-30 | 53.22M shares derived: average of 3 quarters · filed 2022-03-30 | 52.66M shares 10-K · filed 2022-03-30 |
| 2021-09-30 | 53.17M shares 10-Q · filed 2021-11-10 | 53.06M shares derived: average of 2 quarters · filed 2021-11-10 | 52.36M shares 10-Q · filed 2021-11-10 | 51.43M shares derived: average of 4 quarters · filed 2022-03-30 |
| 2021-06-30 | 52.95M shares 10-Q · filed 2021-08-11 | 51.94M shares 10-Q · filed 2021-08-11 | 50.85M shares derived: average of 3 quarters · filed 2022-03-30 | 49.89M shares derived: average of 4 quarters · filed 2022-03-30 |
| 2021-03-31 | 50.93M shares 10-Q · filed 2021-05-11 | 49.80M shares derived: average of 2 quarters · filed 2022-03-30 | 48.87M shares derived: average of 3 quarters · filed 2022-03-30 | 47.51M shares derived: average of 4 quarters · filed 2022-03-30 |
| 2020-12-31 | 48.67M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | 47.85M shares derived: average of 2 quarters · filed 2022-03-30 | 46.37M shares derived: average of 3 quarters · filed 2022-03-30 | 45.28M shares 10-K · filed 2022-03-30 |
| 2020-09-30 | 47.03M shares 10-Q · filed 2021-11-10 | 45.22M shares derived: average of 2 quarters · filed 2021-11-10 | 44.15M shares 10-Q · filed 2021-11-10 | 43.19M shares derived: average of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | 43.41M shares 10-Q · filed 2021-08-11 | 42.31M shares 10-Q · filed 2021-08-11 | 41.91M shares derived: average of 3 quarters · filed 2021-08-11 | 41.40M shares derived: average of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | 41.20M shares 10-Q · filed 2021-05-11 | 41.15M shares derived: average of 2 quarters · filed 2021-05-11 | 40.73M shares derived: average of 3 quarters · filed 2021-05-11 | 40.26M shares derived: average of 4 quarters · filed 2021-05-11 |
| 2019-12-31 | 41.11M shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | 40.49M shares derived: average of 2 quarters · filed 2021-03-22 | 39.95M shares derived: average of 3 quarters · filed 2021-03-22 | 39.18M shares 10-K · filed 2021-03-22 |
| 2019-09-30 | 39.88M shares 10-Q · filed 2020-11-12 | 39.38M shares derived: average of 2 quarters · filed 2020-11-12 | 38.54M shares 10-Q · filed 2020-11-12 | 37.58M shares derived: average of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | 38.88M shares 10-Q · filed 2020-08-13 | 37.27M shares 10-Q · filed 2020-08-13 | 36.81M shares derived: average of 3 quarters · filed 2020-08-13 | 35.81M shares derived: average of 4 quarters · filed 2020-08-13 |
| 2019-03-31 | 36.21M shares 10-Q · filed 2020-05-07 | 35.78M shares derived: average of 2 quarters · filed 2020-05-07 | 34.79M shares derived: average of 3 quarters · filed 2020-05-07 | 33.60M shares derived: average of 4 quarters · filed 2020-05-07 |
| 2018-12-31 | 35.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | 34.08M shares derived: average of 2 quarters · filed 2020-02-20 | 32.73M shares derived: average of 3 quarters · filed 2020-02-20 | 31.39M shares 10-K · filed 2020-02-20 |
| 2018-09-30 | 32.83M shares 10-Q · filed 2019-11-12 | 31.43M shares derived: average of 2 quarters · filed 2019-11-12 | 30.07M shares 10-Q · filed 2019-11-12 | 29.16M shares derived: average of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | 30.03M shares 10-Q · filed 2019-08-12 | 28.66M shares 10-Q · filed 2019-08-12 | 27.94M shares derived: average of 3 quarters · filed 2019-08-12 | 27.58M shares derived: average of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | 27.27M shares 10-Q · filed 2019-05-08 | 26.90M shares derived: average of 2 quarters · filed 2019-05-08 | 26.77M shares derived: average of 3 quarters · filed 2019-05-08 | 26.67M shares derived: average of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | 26.53M shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13 | 26.52M shares derived: average of 2 quarters · filed 2019-03-13 | 26.47M shares derived: average of 3 quarters · filed 2019-03-13 | 26.39M shares 10-K · filed 2019-03-13 |
| 2017-09-30 | 26.51M shares 10-Q · filed 2018-11-07 | 26.45M shares derived: average of 2 quarters · filed 2018-11-07 | 26.34M shares 10-Q · filed 2018-11-07 | 26.25M shares derived: average of 4 quarters · filed 2018-11-07 |
| 2017-06-30 | 26.38M shares 10-Q · filed 2018-08-13 | 26.14M shares 10-Q · filed 2018-08-13 | 26.16M shares derived: average of 3 quarters · filed 2018-08-13 | 25.50M shares derived: average of 4 quarters · filed 2018-08-13 |
| 2017-03-31 | 26.13M shares 10-Q · filed 2018-05-10 | 26.05M shares derived: average of 2 quarters · filed 2018-05-10 | 25.21M shares derived: average of 3 quarters · filed 2018-05-10 | 24.76M shares derived: average of 4 quarters · filed 2018-05-10 |
| 2016-12-31 | 25.97M shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | 24.75M shares derived: average of 2 quarters · filed 2018-03-01 | 24.30M shares derived: average of 3 quarters · filed 2018-03-01 | 23.05M shares 10-K · filed 2018-03-01 |
| 2016-09-30 | 23.52M shares 10-Q · filed 2017-11-09 | 23.47M shares derived: average of 2 quarters · filed 2017-11-09 | 22.08M shares 10-Q · filed 2017-11-09 | 21.16M shares derived: average of 4 quarters · filed 2017-11-09 |
| 2016-06-30 | 23.41M shares 10-Q · filed 2017-08-10 | 21.35M shares 10-Q · filed 2017-08-10 | 20.37M shares derived: average of 3 quarters · filed 2017-08-10 | 19.79M shares derived: average of 4 quarters · filed 2017-08-10 |
| 2016-03-31 | 19.29M shares 10-Q · filed 2017-05-11 | 18.85M shares derived: average of 2 quarters · filed 2017-05-11 | 18.58M shares derived: average of 3 quarters · filed 2017-05-11 | 18.42M shares derived: average of 4 quarters · filed 2017-05-11 |
| 2015-12-31 | 18.42M shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | 18.23M shares derived: average of 2 quarters · filed 2017-03-10 | 18.13M shares derived: average of 3 quarters · filed 2017-03-10 | 17.73M shares 10-K · filed 2017-03-10 |
| 2015-09-30 | 18.04M shares 10-Q · filed 2016-11-10 | 17.99M shares derived: average of 2 quarters · filed 2016-11-10 | 17.50M shares 10-Q · filed 2016-11-10 | |
| 2015-06-30 | 17.95M shares 10-Q · filed 2016-08-11 | 17.21M shares 10-Q · filed 2016-08-11 | ||
| 2015-03-31 | 16.46M shares 10-Q · filed 2016-05-13 | |||
| 2014-12-31 | 13.44M shares 10-K · filed 2016-03-11 | |||
| 2014-03-31 | 12.25M shares 10-Q · filed 2015-05-12 | |||
| 2013-12-31 | 10.83M shares 10-K · filed 2015-03-18 | |||
| 2012-12-31 | 9.36M shares 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |